SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors

    Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors

    Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies led by investigators at the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery.

     READ HERE
    SEE ALL NEWS
    Recent Posts
    Novel Bone Marrow Transplant Can Cure Sickle Cell Disease Scientists Identify Epigenetic Key That ‘Opens’ Door to Colon Cancer Co-located Cell Types Help Drive Aggressive Brain Tumors US surgeon general sounds alarm about link between alcohol and cancer Researchers Develop Biomarker Algorithm for Barrett’s Esophagus and Esophageal Cancer Scientists Identify New Epigenetic Approach to Target Colorectal Cancer Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers How Hypoxia Helps Cancer Spread
    Johns Hopkins

    2025 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top